NSE
Alembic Pharmaceuticals LimitedAPLLTD
Alembic Pharmaceuticals Limited is an Indian pharmaceutical company known for its generic drugs.
| Key products | Generic drugs, APIs (Active Pharmaceutical Ingredients) |
|---|---|
| Geography | India, USA, Europe |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | APLLTDThis | — | — | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — APLLTD day by day
- 2026-06-12FilingAlembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titledPress Release
- 2026-06-11FilingAlembic Pharmaceuticals Limited has informed the Exchange about Credit RatingRating
- 2026-06-11FilingAlembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-11FilingAlembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titledPress Release
- 2026-06-09FilingAlembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Press ReleaseNeutral
a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
Source PDF → - 4
- 1
- 2Press ReleaseNeutral
a press release dated Jun 11, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg".
Source PDF → - 1
No bulk/block deals for APLLTD in this window.
News & chatter on APLLTD
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.